Eris Lifesciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
1,326.55 -33.55 (-2.47%)Updated : 09 Mar 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -405.931,462.81809.0933.50
Net Changein Cash 105.4938.225.1513.96
Cash Taxes Paid 97.88100.7577.2183.29
Net Income/ Starting Line 488.87431.24404.64442.20
Total Cash Dividends Paid -100.050.00-99.91-81.62
Changesin Working Capital 29.86-172.53-245.25-113.19
Cashfrom Operating Activities 1,066.78512.97299.23378.26
Cash Interest Paid 145.0677.3023.433.85
Cashfrom Financing Activities -881.321,379.78688.03-44.70
Issuance( Retirement)of Stock Net 7.224.542.286.75
Depreciation/ Depletion 315.46182.61117.0964.71
Other Investing Cash Flow Items Total 75.03-1,725.36-140.68-198.58
Capital Expenditures -155.00-129.16-841.42-121.03
period Type ----
Non- Cash Items 232.5971.6522.75-15.45
Financing Cash Flow Items -382.56-87.58-23.43-3.32
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -79.97-1,854.52-982.10-319.61
*All figures in crores except per share values
Recommended For You
Trending Stocks
382.75+7.30(1.94%)
2,359.30+14.45(0.62%)
209.15+1.10(0.53%)
1,346.55-95.20 (-6.60%)
1,339.40-86.95 (-6.10%)